Dimitri E. Grigoriadis - Net Worth and Insider Trading
Dimitri E. Grigoriadis Net Worth
The estimated net worth of Dimitri E. Grigoriadis is at least $10 Million dollars as of 2024-09-24. Dimitri E. Grigoriadis is the Chief Research Officer of Neurocrine Biosciences Inc and owns about 82,273 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $10 Million. Details can be seen in Dimitri E. Grigoriadis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dimitri E. Grigoriadis has not made any transactions after 2021-10-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dimitri E. Grigoriadis
Dimitri E. Grigoriadis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dimitri E. Grigoriadis owns 1 companies in total, including Neurocrine Biosciences Inc (NBIX) .
Click here to see the complete history of Dimitri E. Grigoriadis’s form 4 insider trades.
Insider Ownership Summary of Dimitri E. Grigoriadis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2021-10-07 | Vice President & Research |
Dimitri E. Grigoriadis Latest Holdings Summary
Dimitri E. Grigoriadis currently owns a total of 1 stock. Dimitri E. Grigoriadis owns 82,273 shares of Neurocrine Biosciences Inc (NBIX) as of October 7, 2021, with a value of $10 Million.
Latest Holdings of Dimitri E. Grigoriadis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2021-10-07 | 82,273 | 116.61 | 9,593,855 |
Holding Weightings of Dimitri E. Grigoriadis
Dimitri E. Grigoriadis Form 4 Trading Tracker
According to the SEC Form 4 filings, Dimitri E. Grigoriadis has made a total of 11 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Neurocrine Biosciences Inc is the sale of 8,000 shares on October 7, 2021, which brought Dimitri E. Grigoriadis around $838,480.
Insider Trading History of Dimitri E. Grigoriadis
- 1
Dimitri E. Grigoriadis Trading Performance
Dimitri E. Grigoriadis Ownership Network
Dimitri E. Grigoriadis Owned Company Details
What does Neurocrine Biosciences Inc do?
Who are the key executives at Neurocrine Biosciences Inc?
Dimitri E. Grigoriadis is the Vice President & Research of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Corp. Affairs Officer David W. Boyer , Chief Regulatory Officer Ingrid Delaet , and Chief Financial Officer Matt Abernethy .
Neurocrine Biosciences Inc (NBIX) Insider Trades Summary
Over the past 18 months, Dimitri E. Grigoriadis made no insider transaction in Neurocrine Biosciences Inc (NBIX). Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 32,776 shares made by Ingrid Delaet , a net sale of 67,065 shares made by Julie Cooke , and a net sale of 132,270 shares made by Eiry Roberts .
In summary, during the past 3 months, insiders sold 89,288 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 89,288 shares. During the past 18 months, 1,029,798 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,029,798 shares.
Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurocrine Biosciences Inc Insider Transactions
Dimitri E. Grigoriadis Mailing Address
Above is the net worth, insider trading, and ownership report for Dimitri E. Grigoriadis. You might contact Dimitri E. Grigoriadis via mailing address: 12790 El Camino Real, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
